Triglycerides (mmol/l) |
Nandrolone | 1.14 (0.37) | 1.13 (0.22) | 1.37 (0.59) |
Placebo | 1.29 (0.38) | 1.45 (0.58) | 1.30 (0.60) |
Total cholesterol (mmol/l) |
Nandrolone | 4.78 (0.85) | 5.06 (0.57) | 4.72 (0.67) |
Placebo | 5.10 (1.01) | 5.26 (1.37) | 5.16 (0.71) |
HDL-C (mmol/l) |
Nandrolone | 1.13 (0.32) | 1.06 (0.36) | 1.08 (0.30) |
Placebo | 1.16 (0.19) | 1.22 (0.41) | 1.17 (0.37) |
HDL2-C (mmol/l) |
Nandrolone | 0.09 (0.06) | 0.06 (0.05) | 0.07 (0.04) |
Placebo | 0.10 (0.05) | 0.14 (0.20) | 0.13 (0.08) |
HDL3-C (mmol/l) |
Nandrolone | 1.04 (0.30) | 1.00 (0.32) | 1.00 (0.28) |
Placebo | 1.05 (0.15) | 1.07 (0.28) | 1.04 (0.31) |
Apo-A1 (g/l) |
Nandrolone | 1.37 (0.20) | 1.36 (0.29) | 1.39 (0.26) |
Placebo | 1.41 (0.11) | 1.50 (0.25) | 1.49 (0.33) |
Apo-B (g/l) |
Nandrolone | 0.98 (0.23) | 1.08 (0.18) | 0.98 (0.20) |
Placebo | 1.11 (0.32) | 1.13 (0.36) | 1.12 (0.27) |
Lp(a) (U/l) |
Nandrolone | 103 (68) (8–227) | 65 (44)** (8–130) | 89 (66) (12–185) |
Placebo | 245 (245) (38–756) | 201 (194)** (46–617) | 240 (224) (29–657) |